Maryhurst Euphrasia Program

Type of Care

Substance use treatment Mental health treatment Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

Residential/24-hour residential

Facility Type

Other residential treatment facility Residential treatment center (RTC) for children

Pharmacotherapies

Chlorpromazine Aripiprazole Lurasidone Olanzapine Quetiapine Risperidone Antipsychotics used in treatment of SMI

Treatment Approaches

Cognitive behavioral therapy Couples/family therapy Dialectical behavior therapy Eye Movement Desensitization and Reprocessing therapy Group therapy Integrated Mental and Substance Use Disorder treatment Individual psychotherapy

Emergency Mental Health Services

Crisis intervention team

Facility Operation (e.g., Private, Public)

Private non-profit organization

Payment/Insurance/Funding Accepted

Medicaid Other State funds State welfare or child and family services funds

Special Programs/Groups Offered

Clients with co-occurring mental and substance use disorders Clients who have experienced trauma Children/adolescents with serious emotional disturbance (SED)

Testing

HIV testing STD testing TB screening Metabolic syndrome monitoring Laboratory testing

Facility Smoking Policy

Smoking not permitted

Age Groups Accepted

Children/Adolescents Young Adults Adults

Facility Vaping Policy

Vaping not permitted

Ancillary Services

Family psychoeducation Psychosocial rehabilitation services Case management service Suicide prevention services Education services